Published in CA Cancer J Clin on June 01, 2006
Epidemiology of basal-like breast cancer. Breast Cancer Res Treat (2007) 7.08
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst (2010) 4.57
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol (2009) 2.88
Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst (2008) 2.64
Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc (2008) 2.46
Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat (2010) 2.36
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer (2009) 2.21
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04
Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med (2008) 1.93
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev (2010) 1.93
Breast cancer knowledge, attitudes, and screening behaviors among African American women: the Black cosmetologists promoting health program. BMC Public Health (2007) 1.91
Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005. Am J Public Health (2009) 1.90
Tailored interventions to promote mammography screening: a meta-analytic review. Prev Med (2007) 1.83
Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer (2009) 1.81
Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One (2009) 1.72
Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol (2012) 1.63
Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation. Cancer (2009) 1.59
Linking exposure assessment science with policy objectives for environmental justice and breast cancer advocacy: the northern California household exposure study. Am J Public Health (2009) 1.59
Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res (2008) 1.58
Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med (2009) 1.57
Breast cancer chemoprevention: old and new approaches. J Biomed Biotechnol (2012) 1.57
Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol (2011) 1.53
Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Res Treat (2013) 1.53
Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? Cancer Causes Control (2013) 1.46
Male breast cancer: is the scenario changing. World J Surg Oncol (2008) 1.45
Mechanosensitivity in the upper extremity following breast cancer treatment. J Hand Ther (2013) 1.40
Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res (2007) 1.35
Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer (2008) 1.35
Estimating attendance for breast cancer screening in ethnic groups in London. BMC Public Health (2010) 1.35
Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv (2010) 1.34
Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. Br J Cancer (2009) 1.30
A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev (2012) 1.28
Racial segregation and disparities in breast cancer care and mortality. Cancer (2008) 1.28
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol (2010) 1.27
Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res (2007) 1.25
Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. Cancer Res (2012) 1.20
Results of a randomized trial to increase mammogram usage among Samoan women. Cancer Epidemiol Biomarkers Prev (2007) 1.19
Dietary patterns and breast cancer risk in women participating in the Black Women's Health Study. Am J Clin Nutr (2009) 1.18
Ethnic differences in breast cancer survival: status and determinants. Womens Health (Lond Engl) (2011) 1.16
Cancer evolution and individual susceptibility. Integr Biol (Camb) (2011) 1.15
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers. Breast Cancer Res (2007) 1.15
Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials. Am J Public Health (2010) 1.15
Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev (2010) 1.14
Impact of neighborhood racial composition and metropolitan residential segregation on disparities in breast cancer stage at diagnosis and survival between black and white women in California. J Community Health (2010) 1.11
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed (2009) 1.10
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis (2011) 1.10
The costs of breast cancer prior to and following diagnosis. Eur J Health Econ (2010) 1.09
A meta-analysis of interventions to promote mammography among ethnic minority women. Nurs Res (2009) 1.09
Spatial association of racial/ethnic disparities between late-stage diagnosis and mortality for female breast cancer: where to intervene? Int J Health Geogr (2011) 1.06
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev (2012) 1.04
Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women. Breast Cancer Res Treat (2008) 1.04
Innovative approaches to reducing cancer health disparities: the Moffitt Cancer Center Patient Navigator Research Program. J Cancer Educ (2011) 1.03
Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis (2009) 1.03
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res (2008) 1.02
The population-based oncological health care study OVIS - recruitment of the patients and analysis of the non-participants. BMC Cancer (2008) 1.01
Impact of socioeconomic status on extent of lymph node dissection for colon cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.00
Pattern of presentation and survival of breast cancer in a teaching hospital in north Western Nigeria. Oman Med J (2010) 1.00
Transplantation of β-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma. Cancer Res (2011) 0.99
Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities. J Cancer Epidemiol (2013) 0.97
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions. Oncogene (2011) 0.97
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study. Cancer Epidemiol Biomarkers Prev (2015) 0.96
Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome. Cancer (2009) 0.95
Ethnic and socioeconomic trends in breast cancer incidence in New Zealand. BMC Cancer (2010) 0.93
Single nucleotide polymorphism 8q24 rs13281615 and risk of breast cancer: meta-analysis of more than 100,000 cases. PLoS One (2013) 0.92
Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities. Mol Cancer Res (2010) 0.92
Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women. Womens Health Issues (2012) 0.92
Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle. Bioessays (2007) 0.92
Breast cancer incidence and mortality in a Caribbean population: comparisons with African-Americans. Int J Cancer (2009) 0.91
Socioeconomic and racial differences in treatment for breast cancer at a low-volume hospital. Ann Surg Oncol (2011) 0.91
Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancer. PLoS One (2014) 0.90
Improving healthcare empowerment through breast cancer patient navigation: a mixed methods evaluation in a safety-net setting. BMC Health Serv Res (2014) 0.90
Identification of racial disparities in breast cancer mortality: does scale matter? Int J Health Geogr (2010) 0.90
Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin. Cell Death Dis (2014) 0.89
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk. Clinics (Sao Paulo) (2011) 0.89
Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. Br J Cancer (2013) 0.89
Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. Breast Cancer Res (2009) 0.89
Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Clin Breast Cancer (2014) 0.89
Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents. Anticancer Agents Med Chem (2010) 0.88
Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies. Tumour Biol (2014) 0.88
Advances in first-line treatment for patients with HER-2+ metastatic breast cancer. Oncologist (2012) 0.88
Evaluation of an Automated Information Extraction Tool for Imaging Data Elements to Populate a Breast Cancer Screening Registry. J Digit Imaging (2015) 0.87
Breast cancer knowledge, attitudes, and early detection practices in United States-Mexico border Latinas. J Womens Health (Larchmt) (2011) 0.87
Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats. Proc Natl Acad Sci U S A (2008) 0.87
Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. PLoS One (2013) 0.87
Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Res Treat (2013) 0.87
Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer. Int J Surg Oncol (2012) 0.86
Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative. Breast Cancer Res Treat (2013) 0.86
New insights into breast cancer genetics and impact on patient management. Curr Treat Options Oncol (2007) 0.86
Management and outcomes of male breast cancer in zaria, Nigeria. Int J Breast Cancer (2012) 0.86
Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis. BMC Public Health (2013) 0.86
Spatial analysis of county-level breast cancer mortality in Texas. J Environ Public Health (2012) 0.85
The Symptom Cluster of Sleep, Fatigue and Depressive Symptoms in Breast Cancer Patients: Severity of the Problem and Treatment Options. Drug Discov Today Dis Models (2011) 0.85
Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs). Oncotarget (2015) 0.85
Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer: an analysis of more than 90,000 patients from the National Cancer Data Base. J Am Coll Surg (2014) 0.85
Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future? Diagn Pathol (2006) 0.85
Effect of leptin receptor Q223R polymorphism on breast cancer risk. Iran J Basic Med Sci (2014) 0.85
Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden. Oncologist (2011) 0.85
Breast cancer screening practices among first-generation immigrant muslim women. J Womens Health (Larchmt) (2014) 0.84
Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression. Breast Cancer Res Treat (2012) 0.84
Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone. J Assist Reprod Genet (2011) 0.84
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Cancer statistics, 2003. CA Cancer J Clin (2003) 13.46
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Trends in the leading causes of death in the United States, 1970-2002. JAMA (2005) 8.20
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Long-term ozone exposure and mortality. N Engl J Med (2009) 6.90
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin (2007) 4.09
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol (2003) 3.51
American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin (2006) 3.46
Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int (2008) 3.45
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin (2002) 2.94
American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin (2003) 2.91
Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA Cancer J Clin (2008) 2.80
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. Am J Epidemiol (2002) 2.64
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Burden of cervical cancer in the United States, 1998-2003. Cancer (2008) 2.57